SYH2095 for Advanced Malignant Tumors: Phase I Study
SYH2095 for Advanced Malignant Tumors: Phase I Study
Not yet recruiting · NCT07692776 · Registry updated 2026-07-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SYH2095 for Advanced Malignant Tumors: Phase I Study | Advanced Malignant Tumors | Not yet recruiting | Not stated | 2026-07-09 | NCT07692776 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 39 |
| Hangzhou Innogate Pharma Co., Ltd | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tianjin Medical University Cancer Institute and Hospital | Tianjin | China | 1 |